Clotting Data Prompts FDA To Promise Stent Review
The U.S. Food and Drug Administration is concerned about recent study results of the long-term effects of drug-coated stents and will soon look into data at both Boston Scientific Corp. and...To view the full article, register now.
Already a subscriber? Click here to view full article